. Et-sur-le-plan-biologique, 81 %) patient avec hypocomplémentémie -11/16 (69 %) patient avec facteur rhumatoïde -6/13 (46 %) patient avec cryoglobuline

P. Brito-zeron, M. Ramos-casals, and N. Nardi, Circulating Monoclonal Immunoglobulins in Sj??gren Syndrome, Medicine, vol.84, issue.2, pp.90-97, 2005.
DOI : 10.1097/01.md.0000157398.37679.47

J. Gottenberg, F. Aucouturier, and J. Goetz, Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren's syndrome. Ann Rheum Dis publisched online 28, Mar, vol.doi, pp.10-1136, 2006.

J. Mickulicz, Uber eine eigenartige symmetrisch Erkrankung der tranen-und mundspeichldrusen, Beitr Chir Fortschr Gewidmet Theodor Billroth, vol.1892, pp.610-640

H. Gougerot, Insuffisance progressive et atrophie des glandes salivaires et muqueuses de la bouche, des conjonctives [et parfois des muqueuses nasales, laryngées, vulvaires] : « sécheresse » de la bouche, des conjonctives, etc, Bull Soc Franc Derm Syph, vol.32, pp.376-385, 1925.

M. Houvers, Keratisis filamentosa and chronic arthritis, Trans Ophtal Soc UK, vol.47, pp.88-96, 1927.

L. Simon, F. Souyris, and P. Suquet, The salivary glands during rheumatoid arthiritis], Rev Rhum Mal Osteoartic, vol.43, issue.3, pp.185-92, 1976.

K. Bloch, W. Buchanan, and M. Wwohl, SJ??GREN??S SYNDROME, Medicine, vol.44, issue.3, pp.187-231, 1965.
DOI : 10.1097/00005792-196505000-00001

A. Bolstad, R. Wassmuth, and H. Haga, HLA markers and clinical caracteristics i caucasians with primary Sjögren's syndrome, J Rheumatol, vol.28, pp.1554-62, 2001.

E. Thomas, E. Hay, and A. Hajeer, Sjogren's syndrome: a community-based study of prevalence and impact, Rheumatology, vol.37, issue.10, pp.1069-76, 1998.
DOI : 10.1093/rheumatology/37.10.1069

R. Fox and H. Kang, Pathogenesis of Sjögren's syndrome, Rheum Dis Clin North Am, vol.18, issue.3, pp.517-555, 1992.

N. Pavlidis, J. Karsh, and H. Moutsopoulos, The clinical picture of primary Sjögren's syndrome: a retrospective study, J Rheumatol, vol.9, issue.5, pp.685-90, 1982.

P. Hatron, Syndrome de Gougerot-Sjögren, Encyclopédie Pratique de Médecine, pp.5-0280, 1998.

K. Bloch, W. Buchanan, and M. Wwohl, SJ??GREN??S SYNDROME, Medicine, vol.44, issue.3, pp.187-231, 1965.
DOI : 10.1097/00005792-196505000-00001

M. Shearn, Sjögren's syndrome. Philadelphia. WB Saunders company, 1971.

J. Sany and J. Clot, Syndrome de Gougerot-Sjögren. Immuno-Rhumatologie. Ed. médecine sciences Flammarion, pp.189-199, 1989.

E. Papadimitraki, D. Kyrmizakis, and I. Kritikos, Ear-nose-throat manifestations of autoimmune rheumatic diseases, Clin Exp Rheumatol, vol.22, pp.485-94, 2004.

K. Ito, S. Yuyama, and K. Yamashita, A Case Report of Sj??gren???s Syndrome with Repeated False Cord Swelling, ORL, vol.56, issue.3, pp.173-179, 1994.
DOI : 10.1159/000276636

J. Gottenberg, M. Busson, and P. Loiseau, In primary Sj??gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response, Arthritis & Rheumatism, vol.20, issue.8, pp.2240-2245, 2003.
DOI : 10.1006/clin.1994.1150

S. Papiris, M. Saetta, and G. Turato, CD4-Positive T-Lymphocytes Infiltrate the Bronchial Mucosa of Patients with Sj??gren's Syndrome, American Journal of Respiratory and Critical Care Medicine, vol.5, issue.2, pp.637-678, 1997.
DOI : 10.1164/ajrccm/148.5.1358

K. Amin, D. Ludviksdottir, and C. Janson, Inflammation and structural changes in the airways of patients with primary Sj??gren's syndrome, Respiratory Medicine, vol.95, issue.11, pp.904-914, 2001.
DOI : 10.1053/rmed.2001.1174

D. Deheinzelin, V. Capelozzi, and R. Kairalla, Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment

I. Ito, S. Nagai, and M. Kitaichi, Pulmonary Manifestations of Primary Sj??gren's Syndrome, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.6, pp.632-640, 2005.
DOI : 10.1164/rccm.2109039

N. Talal, H. Mousopoulos, and S. Kassan, Sjögren's syndrome : clinical and immunological aspects. Sjögren's syndrome

S. Constantopoulos and H. Moutsopoulos, Respiratory involvement in patients with Sjögren's syndrome: is it a problem, Scand J Rheum, vol.61, p.146, 1986.

M. Garcia-carrasco, M. Ramos-casals, and J. Rosas, Primary Sjögren syndrome : clinical and immunologic disease patterns in a cohort of 400 patients, Medicine[Baltimore], vol.81, issue.4, pp.270-80, 2002.

A. Castro-poltronieri and D. Alarcon-segovia, Articular manifestations of primary Sjögren's syndrome, J Rheumatol, vol.10, issue.3, pp.485-493, 1983.

C. Pease, W. Shattles, and N. Barrett, THE ARTHROPATHY OF SJ??GREN'S SYNDROME, Rheumatology, vol.32, issue.7, pp.609-622, 1993.
DOI : 10.1093/rheumatology/32.7.609

M. Petrovaara, E. Pukkala, and P. Laippala, A longitudinal cohort study of finnish patients with primary Sjögren's syndrome : clinical, immunological, and epidemiological aspects, Ann Rheum Dis, vol.60, issue.5, pp.467-72, 2001.

F. Skopouli, U. Dafni, and J. Ioannidis, Clinical evolution, and morbidity and mortalityof primary Sj??gren's syndrome, Seminars in Arthritis and Rheumatism, vol.29, issue.5, pp.296-304, 2000.
DOI : 10.1016/S0049-0172(00)80016-5

A. Goules, S. Masouridi, and A. Tzioufas, Clinically Significant and Biopsy-Documented Renal Involvement in Primary Sjogren Syndrome, Medicine, vol.79, issue.4, pp.241-250, 2000.
DOI : 10.1097/00005792-200007000-00005

M. Pertovaara, M. Korpela, and T. Kouri, The occurrence of renal involvement in primary Sj??gren's syndrome: a study of 78 patients, Rheumatology, vol.38, issue.11, pp.1113-1133, 1999.
DOI : 10.1136/jcp.36.3.253

N. Talal, E. Zisman, and P. Schur, Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis and Rheumatism1968, pp.774-86
DOI : 10.1002/art.1780110607

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.1780110607/pdf

K. Aasarod, H. Haga, and K. Berg, Renal involvement in primary Sj??gren's syndrome, QJM: An International Journal of Medicine, vol.93, issue.5, pp.297-304, 2000.
DOI : 10.1038/ki.1987.255

C. Raynal, S. Durupt, and I. Durieux, Quadriparésie hypokaliémique avec acidose tubulaire distale révélatrice d'un syndrome de Gougerot-Sjögren primaire, Presse Med, vol.28, pp.1935-1942, 1999.

P. Erikson, T. Denneberg, and S. Eneström, Urolithiasis and distal renal tubular acidosis preceding primary Sjogren's syndrome: a retrospective study 5-53 years after the presentation of urolithiasis, Journal of Internal Medicine, vol.239, issue.6, pp.483-491, 1996.
DOI : 10.1046/j.1365-2796.1996.487829000.x

H. Moutsopoulos, J. Cledes, and F. Skopouli, Nephrocalcinosis in Sj??gren's syndrome: a late sequela of renal tubular acidosis, Journal of Internal Medicine, vol.8, issue.Suppl., pp.187-91, 1991.
DOI : 10.2169/naika.78.424

J. Aerts, C. Vigouroux, and P. Fournier, Ost??omalacie d'origine r??nale r??v??latrice d'un syndrome de Gougerot-Sj??gren, La Revue de M??decine Interne, vol.15, issue.1, pp.43-50, 1994.
DOI : 10.1016/S0248-8663(05)82129-0

M. Fulop and M. Mackay, Renal Tubular Acidosis, Sj??gren Syndrome, and Bone Disease, Archives of Internal Medicine, vol.164, issue.8, pp.905-914, 2004.
DOI : 10.1001/archinte.164.8.905

URL : http://archinte.jamanetwork.com/data/journals/intemed/5484/ioi21035.pdf

K. Joe, U. Jeon, and J. Han, Absence of the H[+]-ATPase in the intercalled cells of renal tissues in classic distal renal tubular acidosis, Clin Nephrol, vol.49, pp.226-257, 1998.

Y. Inagaki, Y. Jinno-yoshida, and Y. Hamasaki, A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sj??gren's syndrome, Journal of Dermatological Science, vol.2, issue.3, pp.147-54, 1991.
DOI : 10.1016/0923-1811(91)90060-B

M. Pertovaara, M. Korpela, and T. Kouri, The occurrence of renal involvement in primary Sj??gren's syndrome: a study of 78 patients, Rheumatology, vol.38, issue.11, pp.1113-1133, 1999.
DOI : 10.1136/jcp.36.3.253

K. Aasarod, H. Haga, and K. Berg, Renal involvement in primary Sj??gren's syndrome, QJM: An International Journal of Medicine, vol.93, issue.5, pp.297-304, 2000.
DOI : 10.1038/ki.1987.255

A. Goules, S. Masouridi, and A. Tzioufas, Clinically Significant and Biopsy-Documented Renal Involvement in Primary Sjogren Syndrome, Medicine, vol.79, issue.4, pp.241-250, 2000.
DOI : 10.1097/00005792-200007000-00005

URL : http://pdfs.journals.lww.com/md-journal/2000/07000/Clinically_Significant_and_Biopsy_Documented_Renal.5.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1506360896155;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzddFRrD2hcIwdDP9eSnSkfswjEvT4rguXIMKVtLonIDIY=;hash|iE4Tc+LbIZVvXh0kosoRvQ==

H. Moutsopoulos, T. Cawley, and N. Stahl, Immune complex glomerulonephritis in sicca syndrome, The American Journal of Medicine, vol.64, issue.6, pp.955-60, 1978.
DOI : 10.1016/0002-9343(78)90449-7

B. Crestani, Manifestations respiratoires au cours du syndrome de Gougerot-Sj??gren, La Revue de M??decine Interne, vol.31, issue.1, pp.7-15, 2010.
DOI : 10.1016/j.revmed.2010.03.012

J. De-seze, S. Delalande, and P. Vermersch, Les manifestations neurologiques du Gougerot-Sj??gren, La Revue de M??decine Interne, vol.26, issue.8, pp.624-660, 2005.
DOI : 10.1016/j.revmed.2005.02.014

M. Garcia-carrasco, R. Casals, M. Rosas, and J. , Primary Sj??gren Syndrome, Medicine, vol.81, issue.4, pp.270-80, 2002.
DOI : 10.1097/00005792-200207000-00003

G. Alexander, T. Prvost, and M. Stevens, Sjogren syndrome: Central nervous system manifestations, Neurology, vol.31, issue.11, pp.1391-1397, 1981.
DOI : 10.1212/WNL.31.11.1391

H. Kaltreider and N. Talal, The Neuropathy of Sj??gren's Syndrome, Annals of Internal Medicine, vol.70, issue.4, pp.751-62, 1969.
DOI : 10.7326/0003-4819-70-4-751

S. Mellgren, D. Conn, and J. Stevens, Peripheral neuropathy in primary Sjogren's syndrome, Neurology, vol.39, issue.3, pp.390-394, 1989.
DOI : 10.1212/WNL.39.3.390

A. Andonopoulos, G. Lagos, and A. Drosos, THE SPECTRUM OF NEUROLOGICAL INVOLVEMENT IN SJ??GREN'S SYNDROME, Rheumatology, vol.29, issue.1, pp.21-24, 1990.
DOI : 10.1093/rheumatology/29.1.21

E. Alexander, T. Provost, and M. Stevens, Neurologic Complications of Primary Sj??gren??s Syndrome, Medicine, vol.61, issue.4, pp.247-57, 1982.
DOI : 10.1097/00005792-198207000-00004

D. Escudero, P. Latorre, and M. Codina, Atteinte du système nerveux central dans le syndrome de Gougerot-Sjögren, Ann Med Interne (Paris), vol.146, pp.239-281, 1995.

R. Molina, T. Provost, and E. Alexander, Peripheral inflammatory vascular disease in Sj??gren's syndrome. Association with nervous system complications, Arthritis & Rheumatism, vol.134, issue.12, pp.1341-1348, 1985.
DOI : 10.1097/00005792-197103000-00001

M. Govoni, G. Bajocchi, and N. Rizzo, Neurological Involvement in Primary Sjo??gren's Syndrome: Clinical and Instrumental Evaluation in a Cohort of Italian Patients, Clinical Rheumatology, vol.18, issue.4, pp.299-303, 1999.
DOI : 10.1007/s100670050105

C. Lafitte, Z. Amoura, and P. Cacoub, Neurological complications of primary Sj??gren's syndrome, Journal of Neurology, vol.248, issue.7, pp.577-84, 2001.
DOI : 10.1007/s004150170135

S. Delalande, J. De-seze, and A. Fauchais, Neurological manifestations in primary Sjögren syndrome: a study of 82 patients, Medicine, vol.83, issue.5, pp.281-91, 2004.

E. Alexander, CNS manifestations of primary Sjögren's syndrome: an overview, Scand J Rheumatol, vol.61, pp.161-166, 1986.

E. Alexander and G. Alexander, Aseptic meningoencephalitis in primary Sjögren's syndrome, Am J Med, vol.33, pp.593-601, 1983.

K. Malinow, R. Molina, and B. Gordon, Neuropsychiatric Dysfunction in Primary Sj??gren's Syndrome, Annals of Internal Medicine, vol.103, issue.3, pp.344-50, 1985.
DOI : 10.7326/0003-4819-103-3-344

G. Kjellen, S. Fransson, and F. Lindstrom, Esophageal function, radiography, and dysphagia in Sj???gren's syndrome, Digestive Diseases and Sciences, vol.58, issue.3, pp.225-234, 1986.
DOI : 10.1007/BF01318111

M. Ramirez-mata, F. Pena-ancira, and D. Alarcon-segovia, Abnormal esophageal motility in primary Sjögren's syndrome, J Rheumatol, vol.3, pp.63-65, 1976.

H. Trevino, E. Tsianos, and S. Schenker, Gastrointestinal and hepatobiliary features in Sjögren's syndrome. Sjögren's syndrome

X. Mariette, Syndrome de Gougerot-Sjögren. Traité des maladies et syndromes systémiques 5è édition, Flammarion ed, pp.495-501, 2008.

. Lancaster, M. Smith, and I. Strickland, AUTOANTIBODIES IN ADULT C??LIAC DISEASE, The Lancet, vol.297, issue.7711, pp.1244-1291, 1971.
DOI : 10.1016/S0140-6736(71)91761-2

C. Goulvestre, Anticorps antinucl??aires, La Presse M??dicale, vol.35, issue.2, pp.287-95, 2006.
DOI : 10.1016/S0755-4982(06)74572-9

E. Tsianos, J. Hoofnagle, and P. Fox, Sj??gren's syndrome in patients with primary biliary cirrhosis, Hepatology, vol.7, issue.5, pp.730-764, 1990.
DOI : 10.7326/0003-4819-79-1-31

H. Ludwig, G. Schernthaner, and O. Scherak, Antibodies to pancreatic duct cells in Sjogren's syndrome and rheumatoid arthritis., Gut, vol.18, issue.4, pp.311-326, 1977.
DOI : 10.1136/gut.18.4.311

J. Webb, K. Whaley, and R. Sween, Liver disease in rheumatoid arthritis and Sjogren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction., Annals of the Rheumatic Diseases, vol.34, issue.1, pp.70-81, 1975.
DOI : 10.1136/ard.34.1.70

. Hradsky, . Bartos, and . Keller, Pancreatic Function in Sj??gren???s Syndrome, Digestion, vol.108, issue.5, pp.252-60, 1971.
DOI : 10.1159/000201622

P. Golding, R. Brown, and A. Mason, "Sicca Complex" in Liver Disease, BMJ, vol.4, issue.5731, pp.340-382, 1970.
DOI : 10.1136/bmj.4.5731.340

G. Herreman, F. Betous, and P. Batisse, Blocs auriculo-ventriculaires détectés in utero chez deux enfants dont la mère a un syndrome de Gougerot-Sjögren, Nouv Press Med, vol.9, p.657, 1982.

M. Shearn, Sjögren's syndrome. Philadelphia.WB Saunders company, 1971.

N. Talal, H. Mousopoulos, and S. Kassan, Sjögren's syndrome : clinical and immunological aspects. Sjögren's syndrome

E. Alexander and T. Provost, Cutaneous Manifestations of Primary Sj??gren's Syndrome: A Reflection of Vasculitis and Association with Anti-RO(SSA) Antibodies, Journal of Investigative Dermatology, vol.80, issue.5, pp.386-91, 1983.
DOI : 10.1111/1523-1747.ep12552002

R. Moulina, T. Provost, and E. Alexander, Two types of inflammatory vascular disease in Sj??gren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia, Arthritis & Rheumatism, vol.1, issue.11, pp.1251-58, 1985.
DOI : 10.1097/00005792-197801000-00001

M. Petrovaara, E. Pukkala, and P. Laippala, A longitudinal cohort study of finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects, Ann Rheum Dis, vol.60, issue.5, pp.467-72, 2001.

N. Haneji, T. Nakamura, and K. Takio, Identification of -Fodrin as a Candidate Autoantigen in Primary Sjögren's Syndrome, Science, vol.276, issue.5312, pp.604-611, 1997.
DOI : 10.1126/science.276.5312.604

T. Witte, M. T. Arnett, and F. , IgA and IgG autoantibodies against alphafodrin as makers for Sjögren's syndrome, J Rheumatol, vol.27, pp.2617-2637, 2000.

C. Sordet, J. Gottenberg, and J. Goetz, Anti-??-fodrin autoantibodies are not useful diagnostic markers of primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.64, issue.8, pp.1244-1289, 2005.
DOI : 10.1136/ard.2004.026419

K. Mori, M. Lijima, and H. Koike, The wide spectrum of clinical manifestations in Sj??gren's syndrome-associated neuropathy, Brain, vol.128, issue.11, pp.2518-2534, 2005.
DOI : 10.1136/jnnp.60.6.699

T. Tzioufas, P. Youinou, H. Moutsopoulos, P. Maddison, D. Isenberg et al., Sjögren's syndrome, Oxford Textbook of Rheumatology, pp.2-1301, 1997.

J. Pablos, P. Carreira, and L. Morillas, Clonally expanded lymphocytes in the minor salivary glands of sj??gren's syndrome patients without lymphoproliferative disease, Arthritis & Rheumatism, vol.46, issue.10, pp.1441-1445, 1994.
DOI : 10.7326/0003-4819-89-6-888

L. Vaillant, S. Ledû, . Bessisd, C. Francès, B. Guillot et al., Syndrome de Gougerot-Sjögren, Dermatologie et Médecine Manifestations dermatologiques des connectivites, vasculites et affections systémiques apparentées, pp.8-9, 2006.

X. Mariette, J. Gozlan, and D. Clerc, Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sj??gren's syndrome, The American Journal of Medicine, vol.90, issue.3, pp.286-94, 1991.
DOI : 10.1016/0002-9343(91)80007-9

S. Miyagawa, K. Dohi, H. Shima, and T. Shirai, Absence of HLA-B8 and HLA-DR3 in Japenese patients with Sjögren's syndrome positive for anti-SSA(Ro), J Rheumatol, vol.19, issue.12, pp.1922-1926, 1992.

J. Gottenberg, M. Busson, and P. Loiseau, In primary Sj??gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response, Arthritis & Rheumatism, vol.20, issue.8, pp.2240-2245, 2003.
DOI : 10.1006/clin.1994.1150

C. Miceli-richard, E. Comets, and P. Loiseau, gene functional polymorphism with Sj??gren's syndrome, Arthritis & Rheumatism, vol.8, issue.12, pp.3989-94, 2007.
DOI : 10.1016/S0002-9440(10)61689-6

T. Hjelmervik, K. Petersen, and I. Jonassen, Gene expression profiling of minor salivary glands clearly distinguishes primary Sj??gren's syndrome patients from healthy control subjects, Arthritis & Rheumatism, vol.263, issue.5, pp.1534-1578, 2005.
DOI : 10.1016/0016-5085(93)90641-O

J. Gottenberg, N. Cagnard, and C. Lucchesi, Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome, Proceedings of the National Academy of Sciences, vol.42, issue.2, pp.2770-2775, 2006.
DOI : 10.1002/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X

X. Mariette and E. Gottenberg, Pathogenesis of Sj??gren??s syndrome and therapeutic consequences, Current Opinion in Rheumatology, vol.22, issue.5, pp.471-478
DOI : 10.1097/BOR.0b013e32833c36c5

J. Gross, J. Johnston, and S. Mudri, TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease, Nature, vol.87, issue.6781, pp.995-1004, 2000.
DOI : 10.1016/S0092-8674(00)81812-7

X. Mariette, S. Roux, and J. Zhang, The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.62, issue.2, pp.168-71, 2003.
DOI : 10.1136/ard.62.2.168

C. Daridon, V. Devauchelle, and P. Hutin, Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.54, issue.4, pp.1134-1178, 2007.
DOI : 10.4049/jimmunol.172.2.762

M. Ittah, C. Miceli-richard, E. Gottenberg, and J. , B cellactivating factor of the tumor necrosis factor family [BAFF] is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome, Arthritis Research & Therapy, vol.8, issue.2, p.51, 2006.
DOI : 10.1186/ar1912

R. Fox and H. Kang, Pathogenesis of Sjögren's syndrome, Rheum Dis Clin North Amer, vol.18, pp.517-555, 1992.

C. Vitali, S. Bombardieri, and R. Jonsson, Classification criteria for Sjögren's syndrome : a revised version of the european criteria proposed by the American- European Consensus Group, Ann Rheum Dis, issue.6, pp.61554-61562, 2002.

O. Van-bijsterveld, Diagnostic Tests in the Sicca Syndrome, Archives of Ophthalmology, vol.82, issue.1, pp.10-14, 1969.
DOI : 10.1001/archopht.1969.00990020012003

C. Vitali, S. Bombardieri, and H. Moutsopoulos, Preliminary criteria for the classification of Sj??gren's syndrome. Results of a prospective concerted action supported by the European community, Arthritis & Rheumatism, vol.10, issue.3, pp.340-347, 1993.
DOI : 10.7326/0003-4819-98-2-155

D. Mason, R. Harden, and J. Boyle, Salivary flow rates and iodide trapping capacity in patients with Sjogren's syndrome., Annals of the Rheumatic Diseases, vol.26, issue.4, pp.311-316, 1967.
DOI : 10.1136/ard.26.4.311

T. Daniels and P. Fox, Salivary and oral components of Sjögren's syndrome, Rheum Dis Clin North Am, vol.18, issue.3, pp.571-89, 1992.

M. Paccalin, P. Roblot, and J. Goujon, Les classifications anatomopathologiques du syndrome de Gougerot-Sj??gren primitif sont-elles corr??l??es entre elles et ?? la clinique?, La Revue de M??decine Interne, vol.18, issue.12, pp.939-944, 1997.
DOI : 10.1016/S0248-8663(97)80113-0

C. Baeteman, L. Guyot, and J. Bouvenot, Faut-il encore effectuer des biopsies des glandes salivaires accessoires???, Revue de Stomatologie et de Chirurgie Maxillo-faciale, vol.109, issue.3, pp.143-147, 2008.
DOI : 10.1016/j.stomax.2007.10.007

M. Fritzler, Autoantibody testing. Procedures and significance in systemic rheumatic diseases, Meth Archiv Exp Pathol, vol.12, pp.224-60, 1986.

W. Elmen, O. Neill, and L. , Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescences and enzyme linked immunosorbent assays, Arthritis Rheum, vol.40, pp.1612-1620, 1997.

R. Humber, Detection of antinuclear antibodies by immunofluorescence in: van Venrooij WJ, Main RN, eds. Manual of biological markers of disease Dordrecht, pp.1-16, 1993.

Z. Amoura, M. Diemert, and L. Musset, Conduite à tenir devant une recherche d'anticorps antinucléaires positive, Médecine Thérapeutique, vol.410, pp.805-810, 1993.

E. Tan, T. Feltkamp, and J. Smolen, Range of antinuclear antibodies in ???healthy??? individuals, Arthritis & Rheumatism, vol.24, issue.9, pp.1601-1612, 1997.
DOI : 10.1002/art.1780400909

P. Youinou, Y. Adler, and S. Muller, Anti-Ro (SS-A) and anti-La(SS-B) antibodies in autoimmune rheumatic diseases, Clin Rev Allergy, vol.12, pp.253-74, 1994.

P. Shur, D. Angelis, D. Jackson, and J. , Immunological detection of nucleic acids and antibodies to nucleic acids by counterimmunoelectrophoresis, Clin Exp Immunol, vol.17, pp.209-254, 1974.

R. Manthrope, P. Oxholm, and J. Prause, The Copenhagen criteria for Sjögren's syndrome, Scand J Rheumatol, vol.61, pp.19-21, 1986.

M. Homma, T. Tojo, and M. Akizuki, Criteria for Sjögren's syndrome in japan, Scand J Rheumatol, vol.61, pp.19-21, 1986.

M. Shearn, Sjögren's syndrome, Major Probl Intern Med, vol.2, pp.1-262, 1971.

F. Skopouli, A. Drosos, and T. Papaioannou, Preliminary diagnostic criteria for Sjögren's syndrome, Scand J Rheumatol, vol.61, pp.22-27, 1986.

R. Fox, C. Robinson, and J. Curd, Sj??gren's syndrome. Proposed criteria for classification, Arthritis & Rheumatism, vol.77, issue.5, pp.577-85, 1986.
DOI : 10.1093/ajcp/65.4.421

G. Kaplan, . Syndrome-de-gougerot-sjögren-kahn, . Peletier, and . Meyer, Les maladies systémiques, Médecine-sciences, pp.499-544, 1991.

C. Vitali, S. Bombardieri, and H. Moutsopoulos, Preliminary criteria for the classification of Sj??gren's syndrome. Results of a prospective concerted action supported by the European community, Arthritis & Rheumatism, vol.10, issue.3, pp.340-347, 1993.
DOI : 10.7326/0003-4819-98-2-155

C. Vitali, S. Bombardieri, and H. Moutsopoulos, Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome., Annals of the Rheumatic Diseases, vol.55, issue.2, pp.116-137, 1996.
DOI : 10.1136/ard.55.2.116

S. Kassan, T. Thomas, and H. Moutsopoulos, Increased Risk of Lymphoma in Sicca Syndrome, Annals of Internal Medicine, vol.89, issue.6, pp.888-92, 1978.
DOI : 10.7326/0003-4819-89-6-888

F. Holm, H. Blomgren, and H. Lowhagen, Cancer Risks in Patients with Chronic Lymphocytic Thyroiditis, New England Journal of Medicine, vol.312, issue.10, pp.601-605
DOI : 10.1056/NEJM198503073121001

T. Peterson, E. Pukkala, and L. Teppo, Increased risk of cancer in patients with systemic lupus erythematosus., Annals of the Rheumatic Diseases, vol.51, issue.4, pp.437-446, 1992.
DOI : 10.1136/ard.51.4.437

G. Frizzera, Immunosuppression, autoimmunity, and lymphoproliferative disorders, Human Pathology, vol.25, issue.7, pp.627-636, 1994.
DOI : 10.1016/0046-8177(94)90293-3

P. Morel, I. Quiquandon, and A. Janin, High incidence of lymphoid infiltration on labial salivary gland biopsy in non-Hodgkin's lymphomas: clinical implications, British Journal of Haematology, vol.299, issue.1, pp.93-101, 1993.
DOI : 10.1016/S0140-6736(88)90367-4

D. Chisholm, J. Waterhouse, and D. Mason, Labial salivary gland biopsy in Sjogren's disease, Journal of Clinical Pathology, vol.21, issue.5, p.656, 1968.
DOI : 10.1136/jcp.21.5.656

URL : http://jcp.bmj.com/content/jclinpath/21/5/656.full.pdf

F. Skopouli, A. Drosos, and T. Papaionnu, Preliminary diagnostic criteria for Sjögren's syndrome. First international symposium on Sjögren's syndrome, Scand J Rheumatol, vol.61, p.22, 1986.

A. Andronopoulos, M. Tiniakou, and M. Melachrinou, Svndrome de Gougerot- Sjögren chez des malades porteurs d'un lymphome non hodgkinien récemment diagnostiqué et non encore traité, Rev Rhum, vol.64, pp.307-319, 1997.

B. Becq-giraudon, L. Yver, and Y. Sudre, Maladie de Waldenstrom associée à un syndrome de Gougerot-Sjögren, Nouv Presse Med, vol.3, pp.137-145, 1976.

N. Talal and W. Bart, Macroglobulinemia in Sjögren's syndrome, J Clin Invest, vol.4, p.109, 1966.

M. Gayraud, L. Guillevin, and O. Blétry, Hypergammaglobulinémie et gammapathie monoclonale au cours du syndrome de Gougerot-Sjögren, Sem Hôp Paris, vol.58, pp.1242-1248, 1982.

R. Cuartero and S. Galan, Sj??gren's syndrome and multiple myeloma, European Journal of Cancer, vol.33, issue.1, pp.167-175, 1997.
DOI : 10.1016/S0959-8049(96)00360-7

B. Bourbigot, G. Potel, and J. Barrier, Association d'un déficit génétique partiel en C4, d'un syndrome de Sjögren et d'un myélome, Presse Méd, vol.12, p.3006, 1983.

M. Casaril, L. Venturini, and R. Pecci, A case of parotideal myeloma in Sjögren's syndrome, Haematologica, vol.72, pp.167-70, 1987.

M. Santos, J. Carretero, L. Armentia, and A. , Hodgkin's disease occurring in primary Sjögren's syndrome, Ann Rheum Dis, vol.9, pp.646-653, 1990.

M. Nagai, K. Sasaki, and M. Tokuda, Hodgkin's disease and Sj??gren's syndrome, European Journal of Haematology, vol.13, issue.3, pp.180-182, 1993.
DOI : 10.1111/j.1600-0609.1993.tb00089.x

F. Gaches, M. Alvarez, and B. Couret, Maladie de Hodgkin avec marqueurs cellulaires du virus Epstein-Barr compliquant l'??volution d'un syndrome de Gougerot-Sj??gren, La Revue de M??decine Interne, vol.18, issue.1, pp.79-80, 1997.
DOI : 10.1016/S0248-8663(97)84399-8

J. Diebold, M. Tulliez, and A. Bernadou, Angiofollicular and plasmacytic polyadenopathy: a pseudotumourous syndrome with dysimmunity., Journal of Clinical Pathology, vol.33, issue.11, pp.1068-70, 1980.
DOI : 10.1136/jcp.33.11.1068

URL : http://jcp.bmj.com/content/jclinpath/33/11/1068.full.pdf

K. Sheibani, J. Burke, and W. Swartz, Monocytoid b-cell lymphoma clinicopathologic study of 21 cases of a unique type of low-grade lymphoma, Cancer, vol.69, issue.8, pp.1531-1539, 1988.
DOI : 10.1093/ajcp/84.2.237

S. Shin, K. Sheibani, and A. Fischleder, Monocytoid B-cell lymphoma in patients with Sj??gren's syndrome: A clinicopathologic study of 13 patients, Human Pathology, vol.22, issue.5, pp.422-452, 1991.
DOI : 10.1016/0046-8177(91)90126-A

J. Dierlamm, S. Pittaluga, and I. Wlodarska, Marginal zone Bcell lymphoma of different sites share similar cytogenetic and morphologic features, Blood, vol.87, pp.299-307, 1996.

W. Wilke, R. Tobbs, and R. Bukowski, T cell lymphoma occurring in Sjögren's syndrome, Arthritis Rheum, vol.27, pp.95-99, 1984.

X. Chevalier, P. Gaulard, and M. Voisin, Peripheral T cell lymphoma with Sjögren's syndrome: a report with immunologic and genotypic studies, J Rheumatol, vol.18, pp.1744-1750, 1991.

K. Lennert, U. Schmid, R. Neth, R. Gallo, M. Greaves et al., Prelymphoma, early lymphoma, and manifest lymphoma inimmunosialadenitis (Sjögren's syndrome) A model of lymphomagenesis, Modern Trends in Human Leukemia, pp.4-18, 1983.

R. Jordan, J. Pringle, and P. Speight, High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization, J Pathol, vol.177, pp.5-40, 1995.

R. Jordan, T. Diss, and N. Lench, Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.79, pp.723-732, 1995.

D. Vita, S. Boiocchi, M. Sorrentino, and D. , Characterization of prelymphomatous stages of B cell lymphoproliferation in Sj??gren's syndrome, Arthritis & Rheumatism, vol.46, issue.2, pp.318-349, 1997.
DOI : 10.1093/ajcp/98.1.116

E. Pisa, P. Pisa, and H. Kang, High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients, Journal of Experimental Medicine, vol.174, issue.5, pp.1245-50, 1991.
DOI : 10.1084/jem.174.5.1245

A. Wotherspoon, T. Finn, and P. Isaacson, Trisomy 3 in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue, Blood, vol.85, pp.2000-2004, 1995.

D. Vita, S. Dolcetti, R. Ferraccioli, and G. , Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome, J Rheumatol, vol.22, pp.1674-80, 1995.

R. Fox, I. Saito, and E. Chan, Viral genomes in lymphomas of patients with Sj??gren's Syndrome, Journal of Autoimmunity, vol.2, issue.4, pp.449-55, 1989.
DOI : 10.1016/0896-8411(89)90174-1

I. Saito, S. Nishimura, and I. Kudo, Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction, Archives of Oral Biology, vol.36, issue.11, pp.779-84, 1991.
DOI : 10.1016/0003-9969(91)90026-Q

B. Royer, D. Cazals-hatem, and J. Sibilia, Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and notal sites, and are not associated with viruses, Blood, vol.90, pp.766-75, 1997.

A. Tzioufas, D. Boumba, and F. Skopouli, Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.36, issue.5, pp.767-72, 1996.
DOI : 10.7326/0003-4819-89-6-888

S. Sugai, S. Shimizu, and J. Tachibana, A high incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sj??gren's syndrome, Journal of Autoimmunity, vol.2, issue.4, pp.471-477, 1989.
DOI : 10.1016/0896-8411(89)90177-7

R. Jordan and P. Speight, Lymphoma in Sj??gren's syndrome, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.81, issue.3, pp.308-328, 1996.
DOI : 10.1016/S1079-2104(96)80331-3

J. Pablos, P. Carreira, and L. Morills, Clonally expanded lymphocytes in the minor salivary glands of Sjögren's syndrome patients without lymphoproliferative disease, Arthritis Rheum, vol.37, pp.141-145, 1994.

C. Vitali, G. Palonbi, and C. Baldini, Sj??gren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sj??gren's syndrome, derived from an analysis of a cohort of Italian patients, Arthritis & Rheumatism, vol.2, issue.7, pp.2223-2254, 2007.
DOI : 10.1016/S0140-6736(86)90837-8

R. Seror, P. Ravaud, and S. Bowman, Eular Sjögren's syndrome Disease Activity Index(ESSDAI) : Developpement of a consensus systemic disease activity index in primary Sjögren's syndrome, Ann Rheum, vol.10, p.1136, 2009.

A. Campar and D. Isenberg, Primary Sj??gren???s syndrome activity and damage indices comparison, European Journal of Clinical Investigation, vol.44, issue.31 Suppl, pp.636-644, 2010.
DOI : 10.1111/j.1365-3083.2008.02185.x

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2362.2010.02303.x/pdf

R. Lawrence, C. Helmick, and F. Arnett, Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States, Arthritis & Rheumatism, vol.42, issue.5, pp.778-99, 1998.
DOI : 10.1097/00007632-198003000-00007

F. Wolfe, H. Smythe, and M. Yunus, The american college of rheumatology 1990 criteria for the classification of fibromyalgia, Arthritis & Rheumatism, vol.29, issue.2, pp.160-72, 1990.
DOI : 10.1002/art.1780330203

M. Yunus, A. Masi, and J. Calabro, Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls, Seminars in Arthritis and Rheumatism, vol.11, issue.1, pp.151-71, 1981.
DOI : 10.1016/0049-0172(81)90096-2

E. Thomas and F. Blotman, Place et signification des sympt??mes non douloureux de la fibromyalgie, Revue du Rhumatisme, vol.70, issue.4, pp.306-315, 2003.
DOI : 10.1016/S1169-8330(03)00099-1

E. Houvenagel and . Fibromyalgie, ), appareil locomoteur, Encycl Méd Chir 15-916-A-10, p.8, 2003.

E. Auxenfants, Le syndrome sec. UNIVADIS médical et davantage, p.114

E. Price and P. Venables, Dry eyes and mouth syndrome--a subgroup of patients presenting with sicca symptoms, Rheumatology, vol.41, issue.4, pp.416-438, 2002.
DOI : 10.1093/rheumatology/41.4.416

J. Champey, E. Corruble, and J. Gottenberg, Quality of life and psychological status in patients with primary Sj??gren's syndrome and sicca symptoms without autoimmune features, Arthritis & Rheumatism, vol.30, issue.3, pp.451-458, 2006.
DOI : 10.1002/art.21990

H. Dinerman, D. Goldenberg, and D. Felson, A prospective evaluation of 118 patients with fibromyalgia syndrome, J Rheumatol, vol.13, pp.368-72, 1986.

A. Barton, B. Pal, and P. Whorwell, Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome, The American Journal of Gastroenterology, vol.112, issue.7, pp.1898-901, 1999.
DOI : 10.1016/S0140-6736(96)90341-4

L. Nelson, J. Fricton, and P. Carlson, Oral Symptoms Associated with Fibromyalgia Syndrome, J Rheumatol, vol.30, pp.1841-1846, 2003.

A. Solomon, Bence-Jones Proteins and Light Chains of Immunoglobulins, New England Journal of Medicine, vol.294, issue.2, pp.91-99, 1976.
DOI : 10.1056/NEJM197601082940206

R. Abraham, M. Charlesworth, and B. Owen, Trimolecular complexes of lambda light chain dimmers in serum of a patient with multiple myeloma, Clin Chem, vol.48, pp.1805-1816, 2002.

K. Solling, Polymeric Forms of Free Light Chains in Serum from Normal Individuals and from Patients with Renal Diseases, Scandinavian Journal of Clinical and Laboratory Investigation, vol.126, issue.5, pp.447-52, 1976.
DOI : 10.1084/jem.126.2.207

L. Musset and S. Choquet, Dosage sérique des chaînes légères libres (CLL) d'immunoglobulines : de la biologie à la clinique. Immuno-analyse et biologie spécialisée, pp.270-278, 2006.
DOI : 10.1016/j.immbio.2006.07.002

J. Katzmann, R. Clark, and R. Abraham, Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, pp.1437-1481, 2002.

A. Bradwell, Serum free light chain analysis, University of Birmingham, issue.5, 2008.

E. C. Freelite, Chronologie et dernière mise à jour, Option Bio, vol.430, 2010.

J. Katzmann, A. Dispensieri, and R. Kyle, Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays, Mayo Clinic Proceedings, vol.81, issue.12, pp.1575-78, 2006.
DOI : 10.4065/81.12.1575

. Hill, Serum Free Light Chains: An Alternative to the Urine Bence Jones Proteins Screening Test for Monoclonal Gammopathies, Clinical Chemistry, vol.52, issue.9, pp.1743-1791, 2006.
DOI : 10.1373/clinchem.2006.069104

J. Katzmann, R. Kyle, and J. Benson, Screening Panels for Detection of Monoclonal Gammopathies, Clinical Chemistry, vol.55, issue.8, pp.1517-1539, 2009.
DOI : 10.1373/clinchem.2009.126664

M. Kyrtsonis, D. Maltezas, and T. Tzenou, Staging Systems and Prognostic Factors as a Guide to Therapeutic Decisions in Multiple Myeloma, Seminars in Hematology, vol.46, issue.2, pp.110-127, 2009.
DOI : 10.1053/j.seminhematol.2009.02.004

B. Durie, J. Harousseau, and J. Miguel, International uniform response criteria for multiple myeloma, Leukemia, vol.27, issue.9, pp.1467-73, 2006.
DOI : 10.1038/sj.bmt.1703035

URL : http://www.nature.com/leu/journal/v20/n9/pdf/2404284a.pdf

A. Dispenzieri, R. Kyle, and G. Merlini, International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders, Leukemia, vol.92, issue.2, pp.215-239, 2009.
DOI : 10.1038/leu.2008.307

H. Lachmann, R. Gallimore, and J. Gillmore, Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy, British Journal of Haematology, vol.50, issue.1, pp.78-84, 2003.
DOI : 10.1038/ki.1996.313

S. Rajkumar, R. Kyle, and T. Therneau, Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance, British Journal of Haematology, vol.8, issue.3, pp.308-318, 2004.
DOI : 10.1046/j.1365-2141.2003.04433.x

J. Katzmann, R. Clark, and S. Roshini, Serum Reference Intervals and Diagnostic Ranges for Free ? and Free ? Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains, Clinical Chemistry, vol.48, issue.9, pp.1437-1481, 2002.

C. Hutchinson, S. Harding, and P. Hewins, Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.3, issue.6, pp.1684-90, 2008.
DOI : 10.2215/CJN.02290508

A. Bradwell, Serum free light chain analysis, University of Birmingham, vol.5, p.112, 2008.

A. Dispenzieri1, R. Kyle, and G. Merlini, International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders, Leukemia, vol.92, issue.2, pp.215-239, 2009.
DOI : 10.1038/leu.2008.307

R. Seror, M. X. Bowman, and S. , Accurate detection of changes in disease activity in primary Sj??gren's syndrome by the European League Against Rheumatism Sj??gren's Syndrome Disease Activity Index, Arthritis Care & Research, vol.29, issue.4, pp.551-559, 2010.
DOI : 10.1093/acprof:oso/9780199231881.001.0001

C. Mavragani, N. Fotini, and M. Haralampos, Increased Prevalence of Antibodies to Thyroid Peroxidase in Dry Eyes and Mouth Syndrome or Sicca Asthenia Polyalgia Syndrome, The Journal of Rheumatology, vol.36, issue.8, p.8, 2009.
DOI : 10.3899/jrheum.081326

A. Fauchais, O. Bali, and G. Gondran, Articular manifestation in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients. Rheumatology Advance Access published, 2010.

K. Whaely, J. Webb, M. Sween, and R. , Sjögren's syndrome. Clinical associations and immunological phenomena, Quart J Med, vol.42, pp.513-116, 1973.

K. Bloch, W. Buchanan, and M. Wwohl, SJ??GREN??S SYNDROME, Medicine, vol.44, issue.3, pp.187-231, 1965.
DOI : 10.1097/00005792-196505000-00001

T. Osial and R. Buckingham, Clinical and serological study of Sjögren's syndrome patients with systemic sclerosis, Arthritis Rheum, vol.30, pp.460-68, 1985.

D. Alarcon-segovia, E. Diaz-jouanen, and E. Fishbein, Features of Sj??gren's Syndrome in Primary Biliary Cirrhosis, Annals of Internal Medicine, vol.79, issue.1, pp.31-36, 1973.
DOI : 10.7326/0003-4819-79-1-31

E. Tsianos, J. Hoofnagle, and P. Fox, Sj??gren's syndrome in patients with primary biliary cirrhosis, Hepatology, vol.7, issue.5, pp.730-734, 1990.
DOI : 10.7326/0003-4819-79-1-31

A. Bohan and J. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-347, 1975.
DOI : 10.1056/NEJM197502132920706

N. Talal, H. Moutsopoulos, and S. Kassan, Sjögren's syndrome: clinical and immunological aspects. Sjögren's syndrome, pp.1-11, 1987.

G. Kaplan, Syndrome de Gougerot-Sjogren. Maladies systémiques, Médecine Sciences Flammarion

J. Gottenberg, M. Busson, and J. Cohen-solal, Correlation of serum B lymphocyte stimulator and ??2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.64, issue.7, pp.1050-55, 2005.
DOI : 10.1136/ard.2004.030643

J. Meijer, P. Meiners, and A. Vissink, Effectiveness of rituximab treatment in primary Sj??gren's syndrome: A randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.68, issue.4, pp.960-968, 2010.
DOI : 10.1113/jphysiol.1972.sp009721

T. Kormelink, J. Tekstra, and R. Thurlings, Decrease in immunoglobulin freelight chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity, Ann Rheum Dis, p.117, 2010.